SELLAS Life Sciences Group, Inc. (SLS) Price
SELLAS Life Sciences Group, Inc.
SLS
$2.04
-$0.08 (-3.77%)
Ano passado
Volume (24h)
$5.677M
Oferta em circulação
142.4M
Capitalização de mercado
$286.3M
Sobre a SELLAS Life Sciences Group, Inc. (SLS)
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company focused on developing novel cancer immunotherapies. Its lead asset, galinpepimut-S, targets a range of cancers including acute myeloid leukemia and mesothelioma. SELLAS operates in a highly specialized field with strong scientific backing and multiple ongoing trials. It aims to deliver targeted, life-extending treatments to patients with unmet medical needs.
Baixar o
Aplicativo móvel Gemini

Indique amigos e ganhe criptomoedas.
Convide amigos para a Gemini, e vocês dois ganharão US$ 50 em criptomoedas quando sua indicação negociar US$ 100 nos primeiros 30 dias.
Tokens mais procurados

Gemini ActiveTrader®
Negocie SELLAS Life Sciences Group, Inc. na plataforma projetada e desenvolvida para traders
Tokens mais procurados
Sobre a SELLAS Life Sciences Group, Inc. (SLS)
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company focused on developing novel cancer immunotherapies. Its lead asset, galinpepimut-S, targets a range of cancers including acute myeloid leukemia and mesothelioma. SELLAS operates in a highly specialized field with strong scientific backing and multiple ongoing trials. It aims to deliver targeted, life-extending treatments to patients with unmet medical needs.
Artigos da Cryptopedia SELLAS Life Sciences Group, Inc.
Dados recentes sobre o preço de SELLAS Life Sciences Group, Inc. (SLS)
O preço de SELLAS Life Sciences Group, Inc. diminuiu em -3.77% nas últimas 24 horas. O preço atual é $2.04 por SELLAS Life Sciences Group, Inc.. A oferta circulante atual é 286.3M SLS.
Última atualização: 2025/12/12 23:56 (UTC)
